| 摘要 |
A crystal for oral solid drug comprised of indoline compound (KMD-3213) which exerts alpha1-adrenaline receptor shielding activity, is useful as a therapeutic agent for dysuria and is represented by the formula: (I) wherein in the powder X-ray diffraction pattern, the compound is characterized by main peaks of 5.5°± 0.2°, 6.1°± 0.2°, 9.8°± 0.2°, 11.1°± 0.2°, 12.2°± 0.2°, 16.4°± 0.2°, 19.7°± 0.2° and 20.0°± 0.2° as 2Theta. There is further provided an oral solid drug for dysuria treatment containing the crystal as an active ingredient.
|
